Bruce Sands, M.D., M.S., is the Dr. Burrill B. Crohn Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York City. After completing his GI fellowship at the Massachusetts General Hospital (MGH), he joined the faculty of Harvard Medical School and served as the Acting Chief of the Gastrointestinal Unit at MGH before moving to Mount Sinai in 2010 as Chief of the Dr. Henry D. Janowitz Division of Gastroenterology. Dr. Sands is widely recognized for his clinical investigations of new therapeutics for the inflammatory bowel diseases and has published over 275 original manuscripts. He was the lead investigator of the landmark studies including ACCENT 2, UNIFI, and VARSITY which were published in the New England Journal of Medicine, and SEAVUE, published in the Lancet. Dr. Sands was awarded his B.A. and M.D. from Boston University, and trained in internal medicine at the Hospital of the University of Pennsylvania.